Cargando…
Editorial: MEDICIS-promed: Advances in radioactive ion beams for nuclear medicine
This special issue highlights advances in the availability of radionuclides for medical application based on developments of the production methods using ion beam and separation technologies. MEDICIS-Promed, a project funded within the H2020 framework program of the European Commission, aimed to tra...
Autores principales: | , , |
---|---|
Lenguaje: | eng |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://dx.doi.org/10.3389/fmed.2022.1013619 http://cds.cern.ch/record/2853287 |
Sumario: | This special issue highlights advances in the availability of radionuclides for medical application based on developments of the production methods using ion beam and separation technologies. MEDICIS-Promed, a project funded within the H2020 framework program of the European Commission, aimed to train young scientists to provide the basis for novel production methods and for systems for personalized medicine, combining functional imaging and treatments based on radioactive ion beam mass-separation.
MEDICIS is an extension of the ISOLDE class A laboratory at CERN. It is a facility dedicated to the production of radionuclides for research in the medical field. It comprises an irradiation station located in the beam dump of the HRS target station, a remote handling system, an isotope mass separation system and a simple radiochemistry laboratory. |
---|